Muhammad Imam, MD, reviews the use of newer antibody-drug conjugates for patients with metastatic breast cancer across subtypes.
Muhammad Imam, MD
Advertisement
Muhammad Imam, MD, is a medical oncologist with Florida Cancer Specialists.
Articles by Muhammad Imam, MD
Advertisement
Latest Updated Articles
Metastatic Breast Cancer Awareness Day: Assessing the Role of ADCsPublished: October 13th 2022 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
